Mayer S, Weiss NS, Chubak J, Doody DR, Malone KE. CYP2D6-inhibiting medication use and inherited variation in relation to adverse breast cancer outcomes after tamoxifen therapy. Poster presented at the 2017 50th Society of Epidemiologic Research Annual Meeting; June 20, 2017. Seattle, WA.

Abstract not available at this time.

Share on: